Not applicableStudy completedNCT04268940What this trial is testingThrombo-Elastography Guided Management of ECMOWho this might be right forExtracorporeal Circulation of Blood; Thrombocytopenia Damian Ratano 61
Not applicableStudy completedNCT00986635What this trial is testingEffect of Rivaroxaban on Coagulation Parameters- an ex Vivo StudyWho this might be right forDifferences in Laboratory Coagulation Parameters Johann Wolfgang Goethe University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04640181What this trial is testingFactor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)Who this might be right forCovid19 St. David's HealthCare 150
Not applicableStudy completedNCT02925247What this trial is testingSpecific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation PatientsWho this might be right forAtrial Fibrillation Assistance Publique Hopitaux De Marseille 150
Post-approval studies (Phase 4)Ended earlyNCT03296033What this trial is testingResidual Anti-Xa Activity After Last Treatment Dose of EnoxaparinWho this might be right forAnticoagulants and Bleeding DisordersSurgeryRegional Anesthesia Morbidity Wake Forest University Health Sciences 122
Very early researchStudy completedNCT02704052What this trial is testingReal-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin DoseWho this might be right forDeep Venous ThrombosisPulmonary EmbolusVenous Thromboembolism University of Utah 116
Not applicableStudy completedNCT05256524What this trial is testingIs Anti-Factor Xa Associated With Outcome in Patients With Critical COVID-19 on Low-Molecular-Weight Heparin?Who this might be right forCovid19ThromboembolismBleeding Karolinska Institutet 1,520
Large-scale testing (Phase 3)Study completedNCT04142125What this trial is testingCombination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic DiseaseWho this might be right forIschemic StrokeIntracranial Atherosclerotic Disease Population Health Research Institute 101
Post-approval studies (Phase 4)Study completedNCT00351663What this trial is testingThe Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill PatientsWho this might be right forVenous ThrombosisCritical Illness Shaare Zedek Medical Center 39
Not applicableLooking for participantsNCT06431789What this trial is testingProspective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal InsufficiencyWho this might be right forGene PolymorphismEdoxabanRenal Insufficiency Yi Han 220
Post-approval studies (Phase 4)Study completedNCT01687491What this trial is testingComparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary SyndromeWho this might be right forAcute Coronary SyndromeFactor X Les Laboratoires des Médicaments Stériles 179
Not applicableStudy completedNCT00319176What this trial is testingEvaluation of Pre-dose and Post-dose Anti-factor Xa Levels With Enoxaparin Use During PregnancyWho this might be right forPregnancy University of California, Irvine 15
Not applicableUnknownNCT04671160What this trial is testingImpact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.Who this might be right forAssessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis Medical University of Gdansk 80
Testing effectiveness (Phase 2)WithdrawnNCT00541320What this trial is testingPhase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)Who this might be right forVenous Thromboembolism GlaxoSmithKline
Not applicableLooking for participantsNCT06383741What this trial is testingPredicting Outcomes in ICH Patients on Direct Factor Xa InhibitorsWho this might be right forIntra Cerebral Hemorrhage Insel Gruppe AG, University Hospital Bern 200
Not applicableStudy completedNCT05221879What this trial is testingAnti-factor Xa Based Venous Thromboembolism ProphylaxisWho this might be right forDose Adjustment of Enoxaparin in ICU Patients Meir Medical Center 75
Not applicableLooking for participantsNCT06357403What this trial is testingAssociation of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill PatientsWho this might be right forThrombosisPulmonary EmbolismEnoxaparin Medical University of Vienna 1,300
Post-approval studies (Phase 4)Looking for participantsNCT06402851What this trial is testingVitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)Who this might be right forAtrium; FibrillationChronic Kidney Diseases Hospital Sirio-Libanes 1,500
Early research (Phase 1)Study completedNCT02687204What this trial is testingTwice Daily Enoxaparin Prophylaxis in Reconstructive Surgery PatientsWho this might be right forVenous ThromboembolismDeep Venous ThrombosisPulmonary Embolus University of Utah 118
Not applicableStudy completedNCT03143569What this trial is testingVentricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility TrialWho this might be right forLeft Sided Heart FailureLeft Ventricular Assist DeviceAnticoagulant Therapy+5 more Washington University School of Medicine 20